Les vaccins curatifs contre les infections à papillomavirus: situation actuelle et perspectivesHANTZ, Sébastien.MTP. Médecine thérapeutique pédiatrie. 2010, Vol 13, Num 1, pp 99-108, issn 1286-5494, 10 p.Article

Syndrome respiratoire aigu sévère et autres coronavirus = Severe acute respiratory syndrome and other coronavirusesHANTZ, Sébastien; DENIS, François.MTP. Médecine thérapeutique pédiatrie. 2012, Vol 15, Num 2, pp 110-122, issn 1286-5494, 13 p.Article

Papillomavirus: les virus et la physiopathologie de l'infectionALAIN, Sophie; HANTZ, Sébastien; DENIS, François et al.MTP. Médecine thérapeutique pédiatrie. 2010, Vol 13, Num 1, pp 5-19, issn 1286-5494, 15 p.Article

Vaccins anti-papillomavirus et prévention du cancer du col de l'utérus : Avancées et perspectives = Anti-papillomavirus vaccines and prevention of cervical cancer : Progress and prospectsHANTZ, Sébastien; ALAIN, Sophie; DENIS, Francois et al.La Presse médicale (1983). 2005, Vol 34, Num 10, pp 745-753, issn 0755-4982, 9 p.Article

Vaccins thérapeutiques ciblant les lésions précancéreuses à papillomavirus = Therapeutic HPV vaccinesHANTZ, Sébastien; ALAIN, Sophie; DENIS, François et al.Virologie (Montrouge). 2011, Vol 15, Num 3, pp 175-191, issn 1267-8694, 17 p.Article

Résistance du Cytomégalovirus aux antiviraux = Cytomegalovirus resistance to antiviral therapyALAIN, Sophie; COTIN, Sébastien; HANTZ, Sébastien et al.Virologie (Montrouge). 2009, Vol 13, Num 4, pp 215-222, issn 1267-8694, 8 p.Article

Traitement des infections à cytomégalovirus humain (CMV)HANTZ, Sébastien; MAZERON, Marie-Christine; ALAIN, Sophie et al.MT. Médecine thérapeutique. 2009, Vol 15, Num 3, pp 211-222, issn 1264-6520, 12 p.Article

Drug-resistant cytomegalovirus in transplant recipients: a French cohort studyHANTZ, Sébastien; GARNIER-GEOFFROY, Françoise; COTIN, Sébastien et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 12, pp 2628-2640, issn 0305-7453, 13 p.Article

Novel DNA polymerase mutations conferring cytomegalovirus resistance: Input of BAC-recombinant phenotyping and 3D modelHANTZ, Sébastien; COTIN, Sébastien; ALAIN, Sophie et al.Antiviral research. 2013, Vol 98, Num 1, pp 130-134, issn 0166-3542, 5 p.Article

Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activityCHAMPIER, Gaël; COUVREUX, Anthony; HANTZ, Sébastien et al.Antiviral therapy (London). 2008, Vol 13, Num 5, pp 643-654, issn 1359-6535, 12 p.Article

Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipientHANTZ, Sébastien; MICHEL, Detlef; ALAIN, Sophie et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 4, pp 1580-1583, issn 0066-4804, 4 p.Article

Two cases of transfusion-transmitted hepatitis B virus (HBV) infection in a low-endemic country before implementation of HBV nucleic acid testingSERVANT-DELMAS, Annabelle; CHUTEAU, Claude; LEFORT, Caroline et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 2, pp 291-296, issn 0041-1132, 6 p.Article

Eight flavonoids and their potential as inhibitors of human cytomegalovirus replicationCOTIN, Sébastien; CALLISTE, Claude-Alain; MAZERON, Marie-Christine et al.Antiviral research. 2012, Vol 96, Num 2, pp 181-186, issn 0166-3542, 6 p.Article

Conserved domains and structure prediction of human cytomegalovirus UL27 proteinHANTZ, Sébastien; COUVREUX, Anthony; CHAMPIER, Gaël et al.Antiviral therapy (London). 2009, Vol 14, Num 5, pp 663-672, issn 1359-6535, 10 p.Article

New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDcCHAMPIER, Gaël; HANTZ, Sébastien; COUVREUX, Anthony et al.Antiviral therapy (London). 2007, Vol 12, Num 2, pp 217-232, issn 1359-6535, 16 p.Article